NCR1 Produkte
(Natural Cytotoxicity Triggering Receptor 1 (NCR1))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte NCR1 Kategorien
NCR1 Antikörper
High quality antibodies with extensive validation data.
NCR1 ELISA Kits
Reliable ELISA kits for a wide range of species.
NCR1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene NCR1 Antikörper
- (3)
- (3)
- (4)
- (3)
Empfohlene NCR1 ELISA Kits
- (1)
Empfohlene NCR1 Proteine
- (4)
- (3)
- (3)
Neueste Publikationen zu unseren NCR1 Produkten
: "Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice." in: Cellular and molecular gastroenterology and hepatology, Vol. 7, Issue 1, pp. 115-134, (2019) (PubMed).: "Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells." in: Biological & pharmaceutical bulletin, Vol. 42, Issue 1, pp. 57-65, (2019) (PubMed).
: "NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 200, Issue 11, pp. 3762-3768, (2018) (PubMed).
: "Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment." in: Oncotarget, Vol. 9, Issue 47, pp. 28364-28378, (2018) (PubMed).
: "Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer." in: Molecular cancer therapeutics, Vol. 17, Issue 10, pp. 2079-2090, (2018) (PubMed).
: "Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization." in: Nature cell biology, Vol. 20, Issue 8, pp. 966-978, (2018) (PubMed).
: "Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey." in: Oncotarget, Vol. 9, Issue 55, pp. 30527-30538, (2018) (PubMed).
: "Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 198, Issue 7, pp. 2589-2601, (2017) (PubMed).
: "NK cell heparanase controls tumor invasion and immune surveillance." in: The Journal of clinical investigation, Vol. 127, Issue 7, pp. 2777-2788, (2017) (PubMed).
: "Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma." in: Molecular therapy oncolytics, Vol. 5, pp. 87-96, (2017) (PubMed).
Synonyme und alternative Namen zu NCR1
natural cytotoxicity triggering receptor 1 (NCR1), natural cytotoxicity triggering receptor 1 (Ncr1), CD335, KILR-1, LY94, Ly94, NK-p46, Nk-p46, NKP46, NKp46, Nkp46Bezeichner auf Proteinebene für NCR1
- NK cell-activating receptor
- lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46)
- natural killer cell p46-related protein
- MAR1 (mouse activating receptor 1)
- NK-p46
- activating receptor 1
- lymphocyte antigen 94
- mAR-1
- mNKp46
- NK receptor KILR-1
- NK-p46)
- NKACTR
- lymphocyte antigen 94 homolog (activating NK-receptor
- rAR-1
- rat-activating receptor 1